Next-Generation Antibody Therapeutics Market Size (USD 14.4 M) by 2032 By Type (Antibody-Drug Conjugates (ADCs), Bispecific Antibodies, Fc-engineered Antibodies, Antibody Fragments and Antibody-like Proteins, Biosimilar Antibody Productss), By Applications Covered (Oncology, Autoimmune/Inflammatory) and Regional Forecast to 2032

Detailed TOC of Global Next-Generation Antibody Therapeutics Industry Research Report 2023, Competitive Landscape, Market Size, Regional Status and Prospect

Table of Content

1 Next-Generation Antibody Therapeutics Market Overview
1.1 Product Overview and Scope of Next-Generation Antibody Therapeutics Market
1.2 Next-Generation Antibody Therapeutics Market Segment by Type
1.2.1 Global Next-Generation Antibody Therapeutics Market Sales Volume and CAGR (%) Comparison by Type (2018-2031)
1.3 Global Next-Generation Antibody Therapeutics Market Segment by Application
1.3.1 Next-Generation Antibody Therapeutics Market Consumption (Sales Volume) Comparison by Application (2018-2031)
1.4 Global Next-Generation Antibody Therapeutics Market, Region Wise (2018-2031)
1.4.1 Global Next-Generation Antibody Therapeutics Market Size (Revenue) and CAGR (%) Comparison by Region (2018-2031)
1.4.2 United States Next-Generation Antibody Therapeutics Market Status and Prospect (2018-2031)
1.4.3 Europe Next-Generation Antibody Therapeutics Market Status and Prospect (2018-2031)
1.4.4 China Next-Generation Antibody Therapeutics Market Status and Prospect (2018-2031)
1.4.5 Japan Next-Generation Antibody Therapeutics Market Status and Prospect (2018-2031)
1.4.6 India Next-Generation Antibody Therapeutics Market Status and Prospect (2018-2031)
1.4.7 Southeast Asia Next-Generation Antibody Therapeutics Market Status and Prospect (2018-2031)
1.4.8 Latin America Next-Generation Antibody Therapeutics Market Status and Prospect (2018-2031)
1.4.9 Middle East and Africa Next-Generation Antibody Therapeutics Market Status and Prospect (2018-2031)
1.5 Global Market Size of Next-Generation Antibody Therapeutics (2018-2031)
1.5.1 Global Next-Generation Antibody Therapeutics Market Revenue Status and Outlook (2018-2031)
1.5.2 Global Next-Generation Antibody Therapeutics Market Sales Volume Status and Outlook (2018-2031)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Next-Generation Antibody Therapeutics Market

2 Industry Outlook
2.1 Next-Generation Antibody Therapeutics Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Next-Generation Antibody Therapeutics Market Drivers Analysis
2.4 Next-Generation Antibody Therapeutics Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Next-Generation Antibody Therapeutics Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Next-Generation Antibody Therapeutics Industry Development

3 Global Next-Generation Antibody Therapeutics Market Landscape by Player
3.1 Global Next-Generation Antibody Therapeutics Sales Volume and Share by Player (2018-2023)
3.2 Global Next-Generation Antibody Therapeutics Revenue and Market Share by Player (2018-2023)
3.3 Global Next-Generation Antibody Therapeutics Average Price by Player (2018-2023)
3.4 Global Next-Generation Antibody Therapeutics Gross Margin by Player (2018-2023)
3.5 Next-Generation Antibody Therapeutics Market Competitive Situation and Trends
3.5.1 Next-Generation Antibody Therapeutics Market Concentration Rate
3.5.2 Next-Generation Antibody Therapeutics Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion

4 Global Next-Generation Antibody Therapeutics Sales Volume and Revenue Region Wise (2018-2023)
4.1 Global Next-Generation Antibody Therapeutics Sales Volume and Market Share, Region Wise (2018-2023)
4.2 Global Next-Generation Antibody Therapeutics Revenue and Market Share, Region Wise (2018-2023)
4.3 Global Next-Generation Antibody Therapeutics Sales Volume, Revenue, Price and Gross Margin (2018-2023)
4.4 United States Next-Generation Antibody Therapeutics Sales Volume, Revenue, Price and Gross Margin (2018-2023)
4.4.1 United States Next-Generation Antibody Therapeutics Market Under COVID-19
4.5 Europe Next-Generation Antibody Therapeutics Sales Volume, Revenue, Price and Gross Margin (2018-2023)
4.5.1 Europe Next-Generation Antibody Therapeutics Market Under COVID-19
4.6 China Next-Generation Antibody Therapeutics Sales Volume, Revenue, Price and Gross Margin (2018-2023)
4.6.1 China Next-Generation Antibody Therapeutics Market Under COVID-19
4.7 Japan Next-Generation Antibody Therapeutics Sales Volume, Revenue, Price and Gross Margin (2018-2023)
4.7.1 Japan Next-Generation Antibody Therapeutics Market Under COVID-19
4.8 India Next-Generation Antibody Therapeutics Sales Volume, Revenue, Price and Gross Margin (2018-2023)
4.8.1 India Next-Generation Antibody Therapeutics Market Under COVID-19
4.9 Southeast Asia Next-Generation Antibody Therapeutics Sales Volume, Revenue, Price and Gross Margin (2018-2023)
4.9.1 Southeast Asia Next-Generation Antibody Therapeutics Market Under COVID-19
4.10 Latin America Next-Generation Antibody Therapeutics Sales Volume, Revenue, Price and Gross Margin (2018-2023)
4.10.1 Latin America Next-Generation Antibody Therapeutics Market Under COVID-19
4.11 Middle East and Africa Next-Generation Antibody Therapeutics Sales Volume, Revenue, Price and Gross Margin (2018-2023)
4.11.1 Middle East and Africa Next-Generation Antibody Therapeutics Market Under COVID-19

5 Global Next-Generation Antibody Therapeutics Sales Volume, Revenue, Price Trend by Type
5.1 Global Next-Generation Antibody Therapeutics Sales Volume and Market Share by Type (2018-2023)
5.2 Global Next-Generation Antibody Therapeutics Revenue and Market Share by Type (2018-2023)
5.3 Global Next-Generation Antibody Therapeutics Price by Type (2018-2023)
5.4 Global Next-Generation Antibody Therapeutics Sales Volume, Revenue and Growth Rate by Type (2018-2023)
5.4.1 Global Next-Generation Antibody Therapeutics Sales Volume, Revenue and Growth Rate of Antibody-Drug Conjugates (ADCs) (2018-2023)
5.4.2 Global Next-Generation Antibody Therapeutics Sales Volume, Revenue and Growth Rate of Bispecific Antibodies (2018-2023)
5.4.3 Global Next-Generation Antibody Therapeutics Sales Volume, Revenue and Growth Rate of Fc-engineered Antibodies (2018-2023)
5.4.4 Global Next-Generation Antibody Therapeutics Sales Volume, Revenue and Growth Rate of Antibody Fragments and Antibody-like Proteins (2018-2023)
5.4.5 Global Next-Generation Antibody Therapeutics Sales Volume, Revenue and Growth Rate of Biosimilar Antibody Products (2018-2023)

6 Global Next-Generation Antibody Therapeutics Market Analysis by Application
6.1 Global Next-Generation Antibody Therapeutics Consumption and Market Share by Application (2018-2023)
6.2 Global Next-Generation Antibody Therapeutics Consumption Revenue and Market Share by Application (2018-2023)
6.3 Global Next-Generation Antibody Therapeutics Consumption and Growth Rate by Application (2018-2023)
6.3.1 Global Next-Generation Antibody Therapeutics Consumption and Growth Rate of Oncology (2018-2023)
6.3.2 Global Next-Generation Antibody Therapeutics Consumption and Growth Rate of Autoimmune/Inflammatory (2018-2023)

7 Global Next-Generation Antibody Therapeutics Market Forecast (2023-2031)
7.1 Global Next-Generation Antibody Therapeutics Sales Volume, Revenue Forecast (2023-2031)
7.1.1 Global Next-Generation Antibody Therapeutics Sales Volume and Growth Rate Forecast (2023-2031)
7.1.2 Global Next-Generation Antibody Therapeutics Revenue and Growth Rate Forecast (2023-2031)
7.1.3 Global Next-Generation Antibody Therapeutics Price and Trend Forecast (2023-2031)
7.2 Global Next-Generation Antibody Therapeutics Sales Volume and Revenue Forecast, Region Wise (2023-2031)
7.2.1 United States Next-Generation Antibody Therapeutics Sales Volume and Revenue Forecast (2023-2031)
7.2.2 Europe Next-Generation Antibody Therapeutics Sales Volume and Revenue Forecast (2023-2031)
7.2.3 China Next-Generation Antibody Therapeutics Sales Volume and Revenue Forecast (2023-2031)
7.2.4 Japan Next-Generation Antibody Therapeutics Sales Volume and Revenue Forecast (2023-2031)
7.2.5 India Next-Generation Antibody Therapeutics Sales Volume and Revenue Forecast (2023-2031)
7.2.6 Southeast Asia Next-Generation Antibody Therapeutics Sales Volume and Revenue Forecast (2023-2031)
7.2.7 Latin America Next-Generation Antibody Therapeutics Sales Volume and Revenue Forecast (2023-2031)
7.2.8 Middle East and Africa Next-Generation Antibody Therapeutics Sales Volume and Revenue Forecast (2023-2031)
7.3 Global Next-Generation Antibody Therapeutics Sales Volume, Revenue and Price Forecast by Type (2023-2031)
7.3.1 Global Next-Generation Antibody Therapeutics Revenue and Growth Rate of Antibody-Drug Conjugates (ADCs) (2023-2031)
7.3.2 Global Next-Generation Antibody Therapeutics Revenue and Growth Rate of Bispecific Antibodies (2023-2031)
7.3.3 Global Next-Generation Antibody Therapeutics Revenue and Growth Rate of Fc-engineered Antibodies (2023-2031)
7.3.4 Global Next-Generation Antibody Therapeutics Revenue and Growth Rate of Antibody Fragments and Antibody-like Proteins (2023-2031)
7.3.5 Global Next-Generation Antibody Therapeutics Revenue and Growth Rate of Biosimilar Antibody Products (2023-2031)
7.4 Global Next-Generation Antibody Therapeutics Consumption Forecast by Application (2023-2031)
7.4.1 Global Next-Generation Antibody Therapeutics Consumption Value and Growth Rate of Oncology(2023-2031)
7.4.2 Global Next-Generation Antibody Therapeutics Consumption Value and Growth Rate of Autoimmune/Inflammatory(2023-2031)
7.5 Next-Generation Antibody Therapeutics Market Forecast Under COVID-19

8 Next-Generation Antibody Therapeutics Market Upstream and Downstream Analysis
8.1 Next-Generation Antibody Therapeutics Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Next-Generation Antibody Therapeutics Analysis
8.6 Major Downstream Buyers of Next-Generation Antibody Therapeutics Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Next-Generation Antibody Therapeutics Industry

9 Players Profiles
9.1 Amgen
9.1.1 Amgen Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Next-Generation Antibody Therapeutics Product Profiles, Application and Specification
9.1.3 Amgen Market Performance (2018-2023)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Roche
9.2.1 Roche Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Next-Generation Antibody Therapeutics Product Profiles, Application and Specification
9.2.3 Roche Market Performance (2018-2023)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Xencor
9.3.1 Xencor Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Next-Generation Antibody Therapeutics Product Profiles, Application and Specification
9.3.3 Xencor Market Performance (2018-2023)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Pfizer
9.4.1 Pfizer Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Next-Generation Antibody Therapeutics Product Profiles, Application and Specification
9.4.3 Pfizer Market Performance (2018-2023)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Bayer
9.5.1 Bayer Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Next-Generation Antibody Therapeutics Product Profiles, Application and Specification
9.5.3 Bayer Market Performance (2018-2023)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Dyax Corp
9.6.1 Dyax Corp Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Next-Generation Antibody Therapeutics Product Profiles, Application and Specification
9.6.3 Dyax Corp Market Performance (2018-2023)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Biogen
9.7.1 Biogen Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Next-Generation Antibody Therapeutics Product Profiles, Application and Specification
9.7.3 Biogen Market Performance (2018-2023)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Bristol-Myers Squibb
9.8.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Next-Generation Antibody Therapeutics Product Profiles, Application and Specification
9.8.3 Bristol-Myers Squibb Market Performance (2018-2023)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Takeda Pharmaceuticals
9.9.1 Takeda Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Next-Generation Antibody Therapeutics Product Profiles, Application and Specification
9.9.3 Takeda Pharmaceuticals Market Performance (2018-2023)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Kyowa Hakko Kirin
9.10.1 Kyowa Hakko Kirin Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Next-Generation Antibody Therapeutics Product Profiles, Application and Specification
9.10.3 Kyowa Hakko Kirin Market Performance (2018-2023)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Seattle Genetics
9.11.1 Seattle Genetics Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Next-Generation Antibody Therapeutics Product Profiles, Application and Specification
9.11.3 Seattle Genetics Market Performance (2018-2023)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 ImmunoGen
9.12.1 ImmunoGen Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Next-Generation Antibody Therapeutics Product Profiles, Application and Specification
9.12.3 ImmunoGen Market Performance (2018-2023)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 AstraZeneca
9.13.1 AstraZeneca Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Next-Generation Antibody Therapeutics Product Profiles, Application and Specification
9.13.3 AstraZeneca Market Performance (2018-2023)
9.13.4 Recent Development
9.13.5 SWOT Analysis

10 Research Findings and Conclusion

11 Appendix
11.1 Methodology
11.2 Research Data Source